Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Ethical considerations in prenatal genomic testing

Horn R. et al, (2024), Best Practice & Research Clinical Obstetrics & Gynaecology, 97, 102548 - 102548

BRCA-DIRECT digital pathway for diagnostic germline genetic testing within a UK breast oncology setting: a randomised, non-inferiority trial.

Torr B. et al, (2024), British journal of cancer, 131, 1506 - 1515

The PS4-likelihood ratio calculator: flexible allocation of evidence weighting for case-control data in variant classification.

Rowlands CF. et al, (2024), Journal of medical genetics, 61, 983 - 991

Balancing the rights of the pre-symptomatic child to be found with the risk of harm to others from the screening process.

Lucassen A. and Horton R., (2024), European journal of human genetics : EJHG

Ethical preparedness in genomic medicine: how NHS clinical scientists navigate ethical issues

Sahan K. et al, (2024), Journal of Medical Ethics, 50, 517 - 522

Ethical and social implications of public-private partnerships in the context of genomic/big health data collection.

Horn R. et al, (2024), European journal of human genetics : EJHG, 32, 736 - 741

Focusing attention on physicians’ climate-related duties may risk missing the bigger picture: towards a systems approach to health and climate

Samuel G. et al, (2024), Journal of Medical Ethics, 50, 380 - 381

Why digital innovation may not reduce healthcare's environmental footprint.

Samuel G. et al, (2024), BMJ (Clinical research ed.), 385

Genomics and insurance in the United Kingdom: increasing complexity and emerging challenges

Dixon P. et al, (2024), Health Economics, Policy and Law, 1 - 13

Discussion of off-target and tentative genomic findings may sometimes be necessary to allow evaluation of their clinical significance.

Horton RH. et al, (2024), Journal of medical ethics, 50, 295 - 298

Predictive genetic testing for Huntington's disease: Exploring participant experiences of uncertainty and ambivalence between clinic appointments.

Ballard LM. et al, (2024), Journal of genetic counseling

Systematic reanalysis of genomic data by diagnostic laboratories: a scoping review of ethical, economic, legal and (psycho)social implications.

van der Geest MA. et al, (2024), European journal of human genetics : EJHG, 32, 489 - 497

Glowing gels and pipettes aplenty: how do commercial stock image banks portray genetic tests?

Horton R. et al, (2024), European journal of human genetics : EJHG, 32, 456 - 460

Advocating for a Context Specific Approach to Tackle Inequities

Samuel G. et al, (2024), The American Journal of Bioethics, 24, 109 - 111

Ancestry, race and ethnicity: the role and relevance of language in clinical genetics practice.

Redman MG. et al, (2024), Journal of medical genetics, 61, 313 - 318

Challenges of using whole genome sequencing in population newborn screening.

Horton R. et al, (2024), BMJ (Clinical research ed.), 384

Secondary (additional) findings from the 100,000 Genomes Project: Disease manifestation, health care outcomes, and costs of disclosure

Nolan J. et al, (2024), Genetics in Medicine, 26, 101051 - 101051

Genomic Data: Building Blocks for Life or Abstract Art?

Horton R. et al, (2024), Frontiers for Young Minds, 12

Population screening requires robust evidence-genomics is no exception.

Turnbull C. et al, (2024), Lancet (London, England), 403, 583 - 586

Prospective study design and data analysis in UK Biobank

Allen NE. et al, (2024), Science Translational Medicine, 16

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?